AxoSim

About:

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.

Twitter/X: axosim

Top Investors: National Science Foundation, National Institutes of Health, Benson Capital Partners, Laconia Ventures, Center for the Advancement of Science in Space

Description:

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim. AxoSim was founded in 2014 and is based in New Orleans, Louisiana.

Total Funding Amount:

$10.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Orleans, Louisiana, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)axosim.com

Founders:

Benjamin Cappiello, J. Lowry Curley

Number of Employees:

11-50

Last Funding Date:

2021-06-10

IPO Status:

Private

Industries: